UCLA received $590 million in NIH funding — second highest total for academic medical centers — in 2020
Cancer researchers Drs. Linda Liau and Mark Litwin among those who awarded research grants
With the motto “turning discovery into health,” the National Institutes of Health’s (NIH) mission is to understand and improve human health by supporting rigorous and innovative medical research through more than $40 billion a year in grants.
To that end, the NIH in 2020 awarded more than $590 million in grants to the David Geffen School of Medicine at UCLA, putting it second in the nation among all academic medical centers in NIH support.
Among those to receive research grants to study cancer were UCLA Jonsson Comprehensive Cancer Center members Dr. Linda Liau, who is collaborating with research faculty in neuroscience, oncology and immunology to develop those brain cancer vaccines and other novel treatments for brain diseases, and Dr. Mark Litwin, who's team work is focused on finding innovative new therapies and using precision medicine to treat patients with prostate, bladder and kidney cancer.
Click here to read the UCLA Health Connect blog.